Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.

Florian Huemer (First author), Verena Schlintl, Stefan Hecht (Co-author), Hubert Hackl, Thomas Melchardt (Co-author), Gabriel Rinnerthaler (Co-author), Richard Greil (Co-author), Lukas Weiss* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)159-166.e3
JournalCLINICAL COLORECTAL CANCER
Volume18
Issue number2
DOIs
Publication statusPublished - 2019

Keywords

  • BODY-COMPOSITION
  • SARCOPENIA
  • TOMOGRAPHY
  • CACHEXIA
  • OBESITY
  • CIRCUMFERENCE
  • MORTALITY
  • SURVIVAL
  • CRITERIA
  • TISSUE

Cite this